-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Equal-Weight on Biogen, Raises Price Target to $231

Benzinga·07/30/2026 17:25:53
Listen to the news
Morgan Stanley analyst Matthew Harrison maintains Biogen (NASDAQ:BIIB) with a Equal-Weight and raises the price target from $222 to $231.